Six versus 2 weeks treatment with doxycycline in European Lyme neuroborreliosis: a multicentre, non-inferiority, double-blinded, randomised and placebo-controlled trial
Conclusion
Our results strongly indicate that there are no benefits of doxycycline treatment beyond 2 weeks in European LNB.
Trial registration number
2015-001481-25.
Source: Journal of Neurology, Neurosurgery and Psychiatry - Category: Neurosurgery Authors: Solheim, A. M., Lorentzen, A. R., Dahlberg, A. O., Flemmen, H. O., Brune, S., Forselv, K. J. N., Pripp, A. H., Bo, M. H., Eikeland, R., Reiso, H., Mygland, A., Ljostad, U. Tags: Open access Neuroinfection Source Type: research
More News: Brain | Doxycycline | Lyme Disease | Neurology | Neurosurgery | Norway Health | Psychiatry